ReviewJournal of clinical medicine2025

Epigenetic Modifications as Novel Biomarkers for Diagnosis, Prognosis, and Therapeutic Targeting in Thyroid, Pancreas, and Lung Neuroendocrine Tumors.

Federica Colapietra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.